Fresenius Medical Care AG & Co. KGaAFMSNYSE
Loading
EBITDA Over TimeStable
Percentile Rank43
3Y CAGR-4.7%
5Y CAGR-6.5%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-4.7%/yr
vs +4.1%/yr prior
5Y CAGR
-6.5%/yr
Consistent
Acceleration
-8.8pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
5 yr
Consecutive declineStable
PeriodValueYoY Change
2025$2.96B-7.8%
2024$3.21B-0.1%
2023$3.21B-6.1%
2022$3.42B-3.7%
2021$3.55B-14.1%
2020$4.13B+5.3%
2019$3.92B+34.9%
2018$2.91B-3.1%
2017$3.00B-1.2%
2016$3.04B-